Zobrazeno 1 - 10
of 1 059
pro vyhledávání: '"H. Van Cauwenberge"'
Publikováno v:
Revue medicale de Liege. 77(4)
Here we present pharmacological and clinical properties of a new fixed triple inhaled combination including an inhaled corticoid, a long acting ?2 agonist and a long acting anticholinergic for the treatment of severe chronic obstructive pulmonary dis
Publikováno v:
Revue medicale de Liege. 77(2)
Chronic obstructive pulmonary disease (COPD) and its exacerbations cause a deterioration in quality of life and a significant consumption of medical resources. Patient empowerment supported by education and self-monitoring practices can improve quali
Publikováno v:
Revue des Maladies Respiratoires. 35:939-947
Resume Objectifs Evaluer la survie apres 1 an d’une oxygenotherapie de longue duree (OLD), rechercher des facteurs predictifs de mortalite a 1 an, evaluer l’impact de l’OLD sur la frequence d’hospitalisation pour exacerbation de bronchopneumo
Autor:
J. Guiot, M. Henket, A.N. Frix, M. Delvaux, A. Denis, L. Giltay, M. Thys, F. Gester, M. Moutschen, J.L. Corhay, R. Louis, A. Ancion, A. Bouquegneau, C. Bovy, G. Darcis, J.O. Defraigne, B. Duysinx, A. Ghuysen, A. Gilbert, V. Heinen, B. Lambermont, O. Malaise, M. Martin, B. Misset, D. Nguyen Dang, J. Piazza, J. Szecel, F. Vaillant, H. Van Cauwenberge, C. Von Frenckell, L. Vroonen
Publikováno v:
Respiratory Investigation
Introduction Patients with interstitial lung diseases (ILD) can be suspected to be at risk of experiencing a rapid flare-up due to COVID-19. However, no specific data are currently available for these patients. Methods We retrospectively analyzed a c
Publikováno v:
Revue medicale de Liege. 74(11)
Following a solicitation of INAMI in 2016, a team of the CHU Liège pneumology department has proposed a telemonitoring pilot project in severe chronic obstructive pulmonary disease (COPD) patients. The main objective of the study was to reduce the n
Publikováno v:
Revue des maladies respiratoires. 35(9)
The aims of this study were to assess the survival rate at one year of patients receiving long-term oxygen therapy (LTOT) as prescribed by the National Institute for Health and Disability Insurance's imposed criteria based on international recommenda
Publikováno v:
Comptes rendus des seances de la Societe de biologie et de ses filiales. 155
Publikováno v:
Comptes rendus des seances de la Societe de biologie et de ses filiales. 155
Publikováno v:
Comptes rendus des seances de la Societe de biologie et de ses filiales. 155
Autor:
H. Van Cauwenberge, M. Nguyen, A.S. Thonnard, Renaud Louis, Jean-Louis Corhay, Vincent Heinen
Publikováno v:
Revue des Maladies Respiratoires. 33:A33
Introduction L’oxygenotherapie de longue duree ameliore la survie des patients BPCO avec hypoxemie severe. Les donnees scientifiques datent du debut des annees 1980. Les dispositifs medicaux d’oxygenotherapie ont evolue et la prise en charge glob